White label ELPA - ClinicalTrials.eu

Study on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2

Recruiting

3 1 1 1
Investigated drugs:
+2
Study on the Use of Flortaucipir for Diagnosing Mild Cognitive Impairment and Dementia in Patients

Recruiting

4 1 1
Investigated diseases:
- Cognitive disorder
- Dementia
Investigated drugs:
- Flortaucipir (18F)
Study on Reducing Tacrolimus in Kidney Transplant Patients with Low Immunological Risk Using Tacrolimus, Mycophenolic Acid, and Prednisone

Recruiting

3 1 1 1
Investigated diseases:
- Renal transplant
Investigated drugs:
Study on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Biliary neoplasm
Investigated drugs:
Study of Oral Vancomycin for Adults and Young Adults with Primary Sclerosing Cholangitis

Recruiting

2 1 1
Investigated diseases:
- Cholangitis sclerosing
Investigated drugs:
- Vancomycin
Study on the Safety and Effects of Radiprodil for Children with GRIN-related Disorder

Recruiting

3 1
Investigated diseases:
- Neurodevelopmental disorder
Investigated drugs:
- Radiprodil
+2
Study of Amivantamab and Chemotherapy Drug Combination for Patients with Advanced or Metastatic Colorectal Cancer

Recruiting

1 1 1 1
Investigated diseases:
- Colorectal cancer
Investigated drugs:
Study on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1

Recruiting

2 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
- Quizartinib Dihydrochloride
+6
Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

Recruiting

4 1 1 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
- Amlitelimab
+7
Study of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Transitional cell cancer of the renal pelvis and ureter
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies